Accordingly, interventions designed to decrease ceramide accumulation, such as overexpression of acid ceramidase in liver or adipose tissue, have been shown to reverse insulin resistance and hepatic steatosis by inhibiting PKC zeta and preventing its insulin‐desensitizing and lipid uptake/fatty acid synthesis‐promoting effects [38]. The gene discussed is ASAH1; the disease is Hepatic steatosis.